Medisystems India Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 03-01-2025
- Paid Up Capital ₹ 7.50 M
as on 03-01-2025
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 Cr
as on 03-01-2025
- Satisfied Charges ₹ 1.40 Cr
as on 03-01-2025
- Revenue 25.04%
(FY 2022)
- Profit 21.68%
(FY 2022)
- Ebitda 17.67%
(FY 2022)
- Net Worth 11.62%
(FY 2022)
- Total Assets 21.34%
(FY 2022)
About Medisystems India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹1.20 Cr. The company has closed loans amounting to ₹1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Parimoo and Sanjay Parimoo serve as directors at the Company.
- CIN/LLPIN
U24231DL1997PTC088591
- Company No.
088591
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medisystems India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Parimoo  | Director | 17-Jul-1997 | Current |
| Ramesh Parimoo | Director | 17-Jul-1997 | Current |
Financial Performance of Medisystems India.
Medisystems India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.04% increase. The company also saw a substantial improvement in profitability, with a 21.68% increase in profit. The company's net worth Soared by an impressive increase of 11.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medisystems India?
In 2020, Medisystems India had a promoter holding of 64.13% and a public holding of 35.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rallith Medisystems Private LimitedActive 15 years 3 monthsRamesh Parimoo and Sanjay Parimoo are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Apr 2024 | ₹1.40 M | Open |
Hdfc Bank Limited Creation Date: 13 Apr 2021 | ₹0.60 M | Open |
Hdfc Bank Limited Creation Date: 14 Aug 2017 | ₹1.00 Cr | Open |
How Many Employees Work at Medisystems India?
Unlock and access historical data on people associated with Medisystems India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medisystems India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medisystems India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
